Dr. Craig W. Stevens

Bio

Craig W. Stevens, M.D., helped to pioneer the use of Intensity Modulated Radiation Therapy (IMRT) for patients with pleural mesothelioma.

The goal of IMRT has been to deliver maximum radiation doses to tumors and cancer cells without impacting healthy tissues and organs nearby. Stevens was one of those who had success by discovering alternative ways to target and direct the IMRP therapy.

As the department chair of Radiation Oncology at the H. Lee Moffitt Cancer Center in Tampa, Stevens has focused on thoracic cavity diseases, including lung cancer and pleural mesothelioma.

At Moffitt, he works with both the Radiation Oncology, Thoracic Oncology and Experimental Therapeutics programs.

His clinical research has focused largely on cancers of the chest. He has worked extensively on lung tumor radiation treatment, planning and predicting the response to radiation of tumor and tissue.

Stevens was board certified for radiation oncology in 1994 and has received numerous awards for his work, including the American Cancer Society Career Development Award. He also is a member of the Lung Committee for Radiation Therapy Oncology Group.

He came to Tampa in 2006 from the M.D. Anderson Cancer Center at the University of Texas.

He received his medical degree from Northwestern University in Chicago, where he also received a Ph.D. in Tumor Biology. He did his internship at Georgetown University Hospital in Washington, D.C.

Publications

Much of Stevens' research focuses on personalized treatment approaches, including the combination of radiation and chemotherapy mesothelioma. His articles have been published in journals such as Radiotherapy Oncology and the Journals of Thoracic Oncology.